Ananda Pharma PLC 2022 AR2
The report outlines Ananda Developments Plc's financial and operational performance for the year ended January 31, 2022. As an early-stage investment company focused on the medical cannabis sector, the company highlighted the UK Home Office licence granted to its investee, DJT Plants Limited, to grow medical cannabis for research. The company reported a loss of £970,343 for the year and focused on promoting long-term shareholder value while considering environmental impacts, aiming for carbon neutrality in its cultivation investments.
Company: Ananda Pharma PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2022
Type: AR2
Pages: 38
Back to company
Ananda Pharma PLC
Audited Financial Statements
The report outlines Ananda Developments Plc's financial and operational performance for the year ended January 31, 2022. As an early-stage investment company focused on the medical cannabis sector, the company highlighted the UK Home Office licence granted to its investee, DJT Plants Limited, to grow medical cannabis for research. The company reported a loss of £970,343 for the year and focused on promoting long-term shareholder value while considering environmental impacts, aiming for carbon neutrality in its cultivation investments.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Feb 1, 2021 - Jan 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees